文献速递乳腺癌放疗放疗物理与技术姑息放疗与转移瘤

美国放射治疗的气候与健康影响:温室气体排放、伤残调整生命年及大分割放疗潜力

The climate and health impact of U.S. radiation therapy: estimating greenhouse gas emissions, DALYs, and potential of hypofractionation.
PubMed 文献 · Radiother Oncol · 2025-09-20

该回顾性分析采用生命周期评估方法,基于2019至2020年美国国家癌症数据库556,426例接受外照射放疗的九类癌症患者数据,量化了美国外照射放疗的温室气体排放(CO2e)及伤残调整生命年(DALYs)损失,并以早期乳腺癌为模型模拟大分割放疗的减排潜力。模拟显示符合条件乳腺癌大分割放疗可减排高达64%。

要点

  • 对应DALYs损失2019年1,040,2020年863。
  • 早期乳腺癌大分割放疗模拟可减排高达64%。

核心结论

  • 建立美国外照射放疗温室气体排放基线可为减排提供基础。
  • 从环境角度审视临床实践可同时改善医疗质量并显著减排。

研究设计与样本

  • 回顾性分析,采用生命周期评估方法,整合患者交通与能源使用真实数据及替代分割方案模拟。
  • 纳入2019至2020年美国国家癌症数据库556,426例接受外照射放疗的九类癌症患者。
  • 其中49,909例早期乳腺癌(I-II期、淋巴结阴性)患者被建模用于大分割放疗情景。

主要发现

  • 2019年对应DALYs损失为1,040,2020年为863。
  • 模拟显示符合条件乳腺癌治疗中增加大分割放疗使用可减排高达64%。

临床怎么用

  • 可参考大分割放疗在符合条件早期乳腺癌中的减排潜力,优化分割方案以降低环境足迹。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/PURPOSE: Climate change is a global crisis, with the healthcare sector contributing 8.5-10 % of greenhouse gas (GHG) emissions in the United States (U.S.). Radiation oncology, particularly through patient transportation for external beam radiation therapy (EBRT), is known to contribute to these emissions. In this study, we aim to quantify the annual GHG emissions in carbon dioxide equivalents (CO2e) from EBRT in the U.S., estimate their down-stream impact on human health in terms of disability-adjusted life-years (DALYs) lost, and evaluate the potential reduction in emissions through increased adoption of hypofractionation, using early-stage breast cancer as a model. MATERIALS/METHODS: This is a retrospective analysis using life cycle assessment (LCA) methodologies, integrating real-world data on patient transportation and energy use, and simulations of alternative fractionation schedules following previously established breast treatment guidelines. The study included 556,426 patients who received EBRT for nine cancer types (breast, central nervous system, gastrointestinal, genitourinary, gynecological, head and neck, musculoskeletal, skin, and thoracic), as recorded in the National Cancer Database (NCDB) in 2019 and 2020. Of these, 49,909 patients with early-stage breast cancer (stages I-II, node-negative) were modeled for hypofractionation scenarios. RESULTS: In 2019 and 2020, EBRT treatments in the U.S. resulted in 3.3 and 2.7 million metric tonnes of CO2e, respectively. Corresponding DALYs lost were 1,040 in 2019 and 863 in 2020. Simulations showed that increasing use of hypofractionation for eligible breast cancer treatments could reduce GHG emissions by up to 64 %. CONCLUSIONS: Establishing baseline U.S. GHG emissions from EBRT offers a foundation for identifying opportunities to mitigate emissions. Investigating clinical practices from an environmental perspective can yield dual benefits: improved quality of care and significant emissions reductions.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Lichter KE, Asaro A, Qureshi MM, et al. The climate and health impact of U.S. radiation therapy: estimating greenhouse gas emissions, DALYs, and potential of hypofractionation. Radiother Oncol. 2025. PMID: 40983187. doi:10.1016/j.radonc.2025.111161

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。